Relationship between anorexia and loss of serotonin uptake sites in brain of mice and rats receiving d-norfenfluramine or d-fenfluramine

Pharmacology Biochemistry and Behavior

Volumn 77, Issue 3, 2004, Pages 541-546

  Rowland, Neil E ^a   Rokadia, Sana ^a   Green, D Joy ^a   Robertson, Kimberly ^a  

^a University of Florida ^*  (United States)

Author keywords

Dessert test; Fos immunoreactivity; Species difference; Synaptosome; Tolerance

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; DEXFENFLURAMINE; NORFENFLURAMINE; PROTEIN FOS; SEROTONIN 2 AGONIST; SEROTONIN TRANSPORTER;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANOREXIA; ANTERIOR HYPOTHALAMUS; ARTICLE; BEHAVIOR; BRAIN NUCLEUS; BRAIN REGION; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG ACTIVITY; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; EXPERIMENTAL TEST; FRONTAL CORTEX; IMMUNOREACTIVITY; INTERMETHOD COMPARISON; LOW DRUG DOSE; MOUSE; NEUROCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN UPTAKE; STATISTICAL SIGNIFICANCE; STRIA TERMINALIS;

ANIMALS; ANOREXIA; BRAIN; FENFLURAMINE; MICE; MICE, INBRED ICR; NORFENFLURAMINE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; SPECIES SPECIFICITY;

TERMINALIS;

EID: 1542330242     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2003.12.007     Document Type: Article

References (28)

1. Appel N.M., Contrera J.F., De Souza E.B. Fenfluramine selectively and differentially decreases the density of serotonergic nerve terminals in rat brain: evidence from immunocytochemical studies. J. Pharmacol. Exp. Ther. 249:1989;928-943.
2. Baumann M.H., Schuster C.R., Rothman R.B. Effect of phentermine and cocaine on fenfluramine-induced depletion of serotonin in mouse brain. Drug Alcohol Depend. 41:1996;71-74.
3. Caccia S., Ballabio G., Guiso M., Rocchetti M., Garattini S. Species differences in the kinetics and metabolism of fenfluramine isomers. Arch. Int. Pharmacodyn. 258:1982;15-28.
4. Caccia S., Anelli M., Ferrarese A., Fracasso C., Garattini S. The role of d-norfenfluramine in the indole-depleting effect of d-fenfluramine in the rat. Eur. J. Pharmacol. 233:1993;71-77.
5. Choi S., Jonak E.M., Simpson L., Patil V., Fernstrom J.D. Intermittent, chronic fenfluramine administration to rats repeatedly suppresses food intake despite substantial brain serotonin reductions. Brain Res. 928:2002;30-39.
6. Fracasso C., Guiso G., Contalonieri S., Bergami A., Garattini S., Caccia S. Depletion and time-course of recovery of brain serotonin after repeated subcutaneous dexfenfluramine in the mouse. A comparison with the rat. Neuropharmacology. 34:1995;1653-1659.
7. Gobbi M., Moia M., Pirona L., Ceglia I., Reyes-Parada M., Scorza C.et al. p-Methylthio-amphetamine and 1-(m-chlorophenyl)piperazine, two non-neurotoxic 5-HT releasers in vivo, differ from neurotoxic amphetamine derivatives in their mode of action at 5-HT nerve endings in vitro. J. Neurochem. 82:2002;1435-1443.
8. Heisler L.K., Colwey M.A., Tecott L.H., Fan W., Low M.J., Smart J.L.et al. Activation of central melanocortin pathways by fenfluramine. Science. 297:2002;609-611.
9. Kleven M.S., Schuster C.R., Seiden L.S. Effect of depletion of brain serotonin by repeated fenfluramine on neurochemical and anorectic effects of acute fenfluramine. J. Pharmacol. Exp. Ther. 246:1988;822-828.
10. Li B.H., Rowland N.E. Effect of chronic dexfenfluramine on Fos in rat brain. Brain Res. 728:1996;188-192.
11. McCann U.D., Yuan J., Hatzidimitriou G., Ricuarte G.A. Selective serotonin reuptake inhibitors dissociate fenfluramine's anorectic and neurotoxic effects: importance of dose, species and drug. J. Pharmacol. Exp. Ther. 281:1997;1487-1498.
12. O'Callaghan J.P., Miller D.B. Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse. J. Pharmacol. Exp. Ther. 270:1994;741-751.
13. Roth J.D., Rowland N.E. Anorectic efficacy of the fenfluramine/ phentermine combination in rats: additivity or synergy? Eur. J. Pharmacol. 373:1999;127-134.
14. Rothman R.B., Baumann M.H. Serotonin releasing agents: neurochemical, therapeutic and adverse effects. Pharmacol. Biochem. Behav. 71:2002;825-836.
15. Rothman R.B., Clark R.D., Partilla J.S., Baumann M.H. (+)-Fenfluramine and its major metabolite, (+)-norfenfluramine, are potent substrates for norepinephrine transporters. J. Pharmacol. Exp. Ther. 305:2003;1191-1199.
16. Rowland N.E. Long-term administration of dexfenfluramine to genetically obese (ob/ob) and lean mice: body weight and brain serotonin changes. Pharmacol. Biochem. Behav. 49:1994;287-294.
17. Rowland N.E., Carlton J. Neurobiology of an anorectic drug: fenfluramine. Prog. Neurobiol. 27:1986;13-62.
18. Rowland N.E., Souquet A.M., Edwards D.J. Long term actions of dexfenfluramine on food intake, body weight, and brain serotonin in rodents. Paoletti R., Vanhoutte D.M., Brunello N., Maggi F.M. Serotonin - from cell biology to pharmacology and therapeutics. 1990;631-635 Kluwer Academic, Dordrecht.
19. Rowland N.E., Roth J.D., McMullen M.R., Patel A., Cespedes A.T. Dexfenfluramine and norfenfluramine: comparison of mechanism of action in feeding and brain Fos-ir studies. Am. J. Physiol. Regul. Integr. Comp. Physiol. 278:2000;R390-399.
20. Rowland N.E., Lo J., Robertson K. Acute anorectic effect of single and combined drugs in mice using a non-deprivation protocol. Psychopharmacology. 157:2001;193-196.
21. 1B/2C agonists in rats. Psychopharmacology. 156:2001;108-114.
22. Rowland N.E., Robertson K., Green D.J. Effect of repeated administration of dexfenfluramine on feeding and brain Fos in mice. Physiol. Behav. 78:2003;295-301.
23. +. J. Pharmacol. Exp. Ther. 290:1999;1363-1368.
24. Souquet A.M., Rowland N.E. Effect of chronic administration of dexfenfluramine on stress- and palatability-induced food intake in rats. Physiol. Behav. 46:1989;145-149.
25. Steranka L.R., Sanders-Bush E. Species differences in the rate of disappearance of fenfluramine and its effects on brain serotonin neurons. Biochem. Pharmacol. 28:1979;3103-3107.
26. Stone D.M., Hanson G.R., Gibb J.W. Differences in the central serotonergic effects of methylene-dioxymethamphetamine (MDMA) in mice and rats. Neuropharmacology. 11:1987;1657-1661.
27. Wellman P.J., Jones S.L., Miller D.K. Effects of pre-exposure to dexfenfluramine, phentermine, dexfenfluramine-phentermine, or fluoxetine on sibutramine-induced hypophagia in the adult rat. Pharmacol. Biochem. Behav. 75:2003;103-114.
28. Zaczek R., Battaglia G., Culp S., Appel N.M., Contrera J.F., De Souza E.B. Effects of repeated fenfluramine administration on indices of monoamine function in rat brain: pharmacokinetic, dose response, regional specificity and time course data. J. Pharmacol. Exp. Ther. 253:1990;104-112.